Sample status
This table gives the status of each sample, either completed successfully or the reason the assembly failed. If applicable the mean quality for the whole construct has been provided, derived by Medaka from aligning the reads to the consensus.
The assembly was generated using Flye. The assemblies and/or inserts were aligned with provided references and marked as expected if they meet both the acceptance criteria defined by the expected_coverage and expected_identity parameters which have been set to 95.0% and 99.0% respectively.Sample | Assembly completed / failed reason | Length | Mean Quality | Expected insert | Expected Assembly |
---|---|---|---|---|---|
sample01 | Failed due to insufficient reads | N/A | N/A | ❌ | ❌ |
sample02 | Completed successfully | 2871 | 52.79 | ✅ | ❌ |
sample03 | Completed successfully | 3096 | 48.08 | ✅ | ✅ |
sample04 | Completed successfully | 3097 | 41.88 | ✅ | ✅ |
sample05 | Completed successfully | 3036 | 52.23 | ✅ | ✅ |
sample06 | Completed successfully | 3037 | 39.08 | ✅ | ✅ |
sample07 | Completed successfully | 3096 | 46.94 | ✅ | ✅ |
sample08 | Completed successfully | 3096 | 46.46 | ✅ | ✅ |
sample09 | Completed successfully | 3036 | 47.16 | ✅ | ✅ |
sample10 | Completed successfully | 3036 | 50.27 | ✅ | ✅ |
sample11 | Completed successfully | 3096 | 44.41 | ✅ | ✅ |
sample12 | Completed successfully | 3096 | 47.78 | ✅ | ✅ |
Plannotate
The Plasmid annotation plot and feature table are produced using pLannotateA pLannotate plot is shown for each assembly. A feature table provides descriptions of the annotated sequence. Unfilled features on the plannotate plots are incomplete features; the sequence match in the plasmid covers less than 95% of the full length of the feature in the database. These elements may be leftover fragments from earlier cloning steps used to create a plasmid. If they include only a small fraction of the feature, they likely do not still have the annotated function. However, even small feature fragments may affect plasmid function if they result in cryptic gene expression or are inadvertently combined with other elements during later cloning steps. The plannotate plot may have overlapping annotation labels, use the zoom and hover tools to decipher the labels.
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
csgG | swissprot | 100.0% | 100.0% | CSGG_ECO57 - Experimental evidence at protein level: Swiss-Prot protein existence level 1. May be involved in the biogenesis of curli organelles. From Escherichia coli O157:H7. | 765 | 1596 | 831 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1659 | 1778 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 1874 | 1965 | 91 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2743 | 554 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 687 | 735 | 48 | - |
KanR | snapgene | 99.3% | 65.7% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 1965 | 2501 | 536 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 1842 | 1874 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 560 | 590 | 30 | - |
kanMX | snapgene | 99.0% | 37.3% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 1995 | 2501 | 506 | + |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 2741 | 2844 | 103 | - |
KanR | snapgene | 99.1% | 14.2% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2501 | 2616 | 115 | + |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2622 | 2719 | 98 | + |
kanMX | snapgene | 99.1% | 8.5% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2501 | 2616 | 115 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 1884 | 1966 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
TXL_EISFE | swissprot | 100.0% | 100.0% | Experimental evidence at protein level: Swiss-Prot protein existence level 1. Pore-forming toxin that defensively acts against parasitic microorganisms by forming pores in sphingomyelin-containing membranes. Has hemolytic activity and is also cytotoxic to spermatozoa of some species of invertebrates and many species of vertebrates and to amphibian larvae, guinea pig polymorphonuclear leukocytes, chicken fibroblasts, normal spleen cells and various tumor cells. Is lethal for various species of reptiles, amphibian, birds and mammals. Induces smooth muscle contraction. It binds sphingomyelin and induces hemolysis in the same manner as lysenin-related protein 2, and is 10-fold more effective than lysenin-related protein 1. | 909 | 1800 | 891 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1863 | 1982 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 2078 | 2169 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2169 | 2985 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 16 | 698 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 831 | 879 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2199 | 2985 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 2046 | 2078 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 704 | 734 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 14 | 117 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2991 | 3088 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 2088 | 2170 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
TXL_EISFE | swissprot | 100.0% | 100.0% | Experimental evidence at protein level: Swiss-Prot protein existence level 1. Pore-forming toxin that defensively acts against parasitic microorganisms by forming pores in sphingomyelin-containing membranes. Has hemolytic activity and is also cytotoxic to spermatozoa of some species of invertebrates and many species of vertebrates and to amphibian larvae, guinea pig polymorphonuclear leukocytes, chicken fibroblasts, normal spleen cells and various tumor cells. Is lethal for various species of reptiles, amphibian, birds and mammals. Induces smooth muscle contraction. It binds sphingomyelin and induces hemolysis in the same manner as lysenin-related protein 2, and is 10-fold more effective than lysenin-related protein 1. | 909 | 1800 | 891 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1863 | 1982 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 2078 | 2169 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2169 | 2985 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 16 | 698 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 831 | 879 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2199 | 2985 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 2046 | 2078 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 704 | 734 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 14 | 117 | 103 | - |
CloDF13 ori | snapgene | 100.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2991 | 3089 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 2088 | 2170 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
csgG | swissprot | 100.0% | 100.0% | CSGG_ECO57 - Experimental evidence at protein level: Swiss-Prot protein existence level 1. May be involved in the biogenesis of curli organelles. From Escherichia coli O157:H7. | 765 | 1596 | 831 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1659 | 1778 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 1874 | 1965 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 1965 | 2781 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2908 | 554 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 687 | 735 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 1995 | 2781 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 1842 | 1874 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 560 | 590 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 2906 | 3009 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2787 | 2884 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 1884 | 1966 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
csgG | swissprot | 100.0% | 100.0% | CSGG_ECO57 - Experimental evidence at protein level: Swiss-Prot protein existence level 1. May be involved in the biogenesis of curli organelles. From Escherichia coli O157:H7. | 765 | 1596 | 831 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1659 | 1778 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 1874 | 1965 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 1965 | 2781 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2909 | 554 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 687 | 735 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 1995 | 2781 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 1842 | 1874 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 560 | 590 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 2907 | 3010 | 103 | - |
CloDF13 ori | snapgene | 100.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2787 | 2885 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 1884 | 1966 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
TXL_EISFE | swissprot | 100.0% | 100.0% | Experimental evidence at protein level: Swiss-Prot protein existence level 1. Pore-forming toxin that defensively acts against parasitic microorganisms by forming pores in sphingomyelin-containing membranes. Has hemolytic activity and is also cytotoxic to spermatozoa of some species of invertebrates and many species of vertebrates and to amphibian larvae, guinea pig polymorphonuclear leukocytes, chicken fibroblasts, normal spleen cells and various tumor cells. Is lethal for various species of reptiles, amphibian, birds and mammals. Induces smooth muscle contraction. It binds sphingomyelin and induces hemolysis in the same manner as lysenin-related protein 2, and is 10-fold more effective than lysenin-related protein 1. | 909 | 1800 | 891 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1863 | 1982 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 2078 | 2169 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2169 | 2985 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 16 | 698 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 831 | 879 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2199 | 2985 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 2046 | 2078 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 704 | 734 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 14 | 117 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2991 | 3088 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 2088 | 2170 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
TXL_EISFE | swissprot | 100.0% | 100.0% | Experimental evidence at protein level: Swiss-Prot protein existence level 1. Pore-forming toxin that defensively acts against parasitic microorganisms by forming pores in sphingomyelin-containing membranes. Has hemolytic activity and is also cytotoxic to spermatozoa of some species of invertebrates and many species of vertebrates and to amphibian larvae, guinea pig polymorphonuclear leukocytes, chicken fibroblasts, normal spleen cells and various tumor cells. Is lethal for various species of reptiles, amphibian, birds and mammals. Induces smooth muscle contraction. It binds sphingomyelin and induces hemolysis in the same manner as lysenin-related protein 2, and is 10-fold more effective than lysenin-related protein 1. | 909 | 1800 | 891 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1863 | 1982 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 2078 | 2169 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2169 | 2985 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 16 | 698 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 831 | 879 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2199 | 2985 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 2046 | 2078 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 704 | 734 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 14 | 117 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2991 | 3088 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 2088 | 2170 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
csgG | swissprot | 100.0% | 100.0% | CSGG_ECO57 - Experimental evidence at protein level: Swiss-Prot protein existence level 1. May be involved in the biogenesis of curli organelles. From Escherichia coli O157:H7. | 765 | 1596 | 831 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1659 | 1778 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 1874 | 1965 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 1965 | 2781 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2908 | 554 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 687 | 735 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 1995 | 2781 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 1842 | 1874 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 560 | 590 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 2906 | 3009 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2787 | 2884 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 1884 | 1966 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
csgG | swissprot | 100.0% | 100.0% | CSGG_ECO57 - Experimental evidence at protein level: Swiss-Prot protein existence level 1. May be involved in the biogenesis of curli organelles. From Escherichia coli O157:H7. | 765 | 1596 | 831 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1659 | 1778 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 1874 | 1965 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 1965 | 2781 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2908 | 554 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 687 | 735 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 1995 | 2781 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 1842 | 1874 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 560 | 590 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 2906 | 3009 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 2787 | 2884 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 1884 | 1966 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
TXL_EISFE | swissprot | 100.0% | 100.0% | Experimental evidence at protein level: Swiss-Prot protein existence level 1. Pore-forming toxin that defensively acts against parasitic microorganisms by forming pores in sphingomyelin-containing membranes. Has hemolytic activity and is also cytotoxic to spermatozoa of some species of invertebrates and many species of vertebrates and to amphibian larvae, guinea pig polymorphonuclear leukocytes, chicken fibroblasts, normal spleen cells and various tumor cells. Is lethal for various species of reptiles, amphibian, birds and mammals. Induces smooth muscle contraction. It binds sphingomyelin and induces hemolysis in the same manner as lysenin-related protein 2, and is 10-fold more effective than lysenin-related protein 1. | 928 | 1819 | 891 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1882 | 2001 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 2097 | 2188 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2188 | 3004 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 35 | 717 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 850 | 898 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2218 | 3004 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 2065 | 2097 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 723 | 753 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 33 | 136 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 3010 | 11 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 2107 | 2189 | 82 | + |
Feature | Database | Identity | Match Length | Description | Start Location | End Location | Length | Strand |
---|---|---|---|---|---|---|---|---|
TXL_EISFE | swissprot | 100.0% | 100.0% | Experimental evidence at protein level: Swiss-Prot protein existence level 1. Pore-forming toxin that defensively acts against parasitic microorganisms by forming pores in sphingomyelin-containing membranes. Has hemolytic activity and is also cytotoxic to spermatozoa of some species of invertebrates and many species of vertebrates and to amphibian larvae, guinea pig polymorphonuclear leukocytes, chicken fibroblasts, normal spleen cells and various tumor cells. Is lethal for various species of reptiles, amphibian, birds and mammals. Induces smooth muscle contraction. It binds sphingomyelin and induces hemolysis in the same manner as lysenin-related protein 2, and is 10-fold more effective than lysenin-related protein 1. | 928 | 1819 | 891 | - |
rhaB promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli rhaBAD operon, conferring tight induction with L-rhamnose and repression with D-glucose in the presence of RhaR and RhaS (Giacalone et al., 2006) | 1882 | 2001 | 119 | - |
cat promoter | snapgene | 100.0% | 100.0% | promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase | 2097 | 2188 | 91 | + |
KanR | snapgene | 99.4% | 100.0% | aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin®) in eukaryotes | 2188 | 3004 | 816 | + |
CloDF13 ori | snapgene | 100.0% | 92.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 35 | 717 | 682 | + |
T7 terminator | snapgene | 100.0% | 100.0% | transcription terminator for bacteriophage T7 RNA polymerase | 850 | 898 | 48 | - |
kanMX | snapgene | 99.2% | 57.9% | yeast selectable marker conferring kanamycin resistance (Wach et al., 1994) | 2218 | 3004 | 786 | + |
tonB terminator | snapgene | 100.0% | 100.0% | bidirectional E. coli tonB-P14 transcription terminator | 2065 | 2097 | 32 | + |
T3Te terminator | snapgene | 100.0% | 100.0% | phage T3 early transcription terminator | 723 | 753 | 30 | - |
RNAI | Rfam | 100.0% | 99.0% | Accession: RF00106 - RNAI | 33 | 136 | 103 | - |
CloDF13 ori | snapgene | 99.0% | 13.3% | Plasmids containing the CloDF13 (CDF) origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins. | 3010 | 11 | 98 | + |
PDK intron | snapgene | 100.0% | 5.1% | pdk; modified pyruvate orthophosphate dikinase intron from Flaveria trinervia 3.0 | 2107 | 2189 | 82 | + |
Read Counts
Number of reads per sample.
Read stats
For each assembly, read length statistics and plots of quality before and after host filtering, and after downsampling if a host reference was provided.
Failed due to insufficient reads
Read count
149
Read count
149
Completed successfully
Read count
1,334
Read count
1,332
Read count
206
Completed successfully
Read count
1,334
Read count
1,333
Read count
200
Completed successfully
Read count
1,334
Read count
1,334
Read count
206
Completed successfully
Read count
1,334
Read count
1,332
Read count
226
Completed successfully
Read count
1,334
Read count
1,330
Read count
220
Completed successfully
Read count
1,334
Read count
1,331
Read count
208
Completed successfully
Read count
1,334
Read count
1,330
Read count
206
Completed successfully
Read count
1,334
Read count
1,331
Read count
206
Completed successfully
Read count
1,334
Read count
1,332
Read count
210
Completed successfully
Read count
1,334
Read count
1,333
Read count
211
Completed successfully
Read count
1,334
Read count
1,332
Read count
203
Insert sequences
This table shows which primers were found in the consensus sequence of each sample and where the inserts were found.
Sample | start | end | primer | strand | Insert length |
---|---|---|---|---|---|
sample02 | 526 | 1655 | pRham | - | 1129 |
sample05 | 526 | 1655 | pRham | - | 1129 |
sample06 | 526 | 1655 | pRham | - | 1129 |
sample09 | 526 | 1655 | pRham | - | 1129 |
sample10 | 526 | 1655 | pRham | - | 1129 |
This table shows which primers were found in the consensus sequence of each sample and where the inserts were found.
Sample | start | end | primer | strand | Insert length |
---|---|---|---|---|---|
sample03 | 670 | 1859 | pRham | - | 1189 |
sample04 | 670 | 1859 | pRham | - | 1189 |
sample07 | 670 | 1859 | pRham | - | 1189 |
sample08 | 670 | 1859 | pRham | - | 1189 |
sample11 | 689 | 1878 | pRham | - | 1189 |
sample12 | 689 | 1878 | pRham | - | 1189 |
Multiple Sequence Alignment
This section shows the inserts aligned with each other or a reference sequence if provided.
Reference GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGCAGCGTCTGTTTCTGCTG sample02 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGCAGCGTCTGTTTCTGCTG sample05 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGCAGCGTCTGTTTCTGCTG sample06 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGCAGCGTCTGTTTCTGCTG sample09 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGCAGCGTCTGTTTCTGCTG sample10 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGCAGCGTCTGTTTCTGCTG Reference GTCGCGGTGATGCTGCTGAGTGGTTGTCTGACCGCACCGCCGAAAGAAGCGGCACGTCCGACCCTGATGCCGCGTGCACA sample02 GTCGCGGTGATGCTGCTGAGTGGTTGTCTGACCGCACCGCCGAAAGAAGCGGCACGTCCGACCCTGATGCCGCGTGCACA sample05 GTCGCGGTGATGCTGCTGAGTGGTTGTCTGACCGCACCGCCGAAAGAAGCGGCACGTCCGACCCTGATGCCGCGTGCACA sample06 GTCGCGGTGATGCTGCTGAGTGGTTGTCTGACCGCACCGCCGAAAGAAGCGGCACGTCCGACCCTGATGCCGCGTGCACA sample09 GTCGCGGTGATGCTGCTGAGTGGTTGTCTGACCGCACCGCCGAAAGAAGCGGCACGTCCGACCCTGATGCCGCGTGCACA sample10 GTCGCGGTGATGCTGCTGAGTGGTTGTCTGACCGCACCGCCGAAAGAAGCGGCACGTCCGACCCTGATGCCGCGTGCACA Reference GTCTTATAAAGATCTGACCCATCTGCCGGCTCCGACGGGCAAAATTTTTGTTAGCGTCTATAACATCCAGGACGAAACCG sample02 GTCTTATAAAGATCTGACCCATCTGCCGGCTCCGACGGGCAAAATTTTTGTTAGCGTCTATAACATCCAGGACGAAACCG sample05 GTCTTATAAAGATCTGACCCATCTGCCGGCTCCGACGGGCAAAATTTTTGTTAGCGTCTATAACATCCAGGACGAAACCG sample06 GTCTTATAAAGATCTGACCCATCTGCCGGCTCCGACGGGCAAAATTTTTGTTAGCGTCTATAACATCCAGGACGAAACCG sample09 GTCTTATAAAGATCTGACCCATCTGCCGGCTCCGACGGGCAAAATTTTTGTTAGCGTCTATAACATCCAGGACGAAACCG sample10 GTCTTATAAAGATCTGACCCATCTGCCGGCTCCGACGGGCAAAATTTTTGTTAGCGTCTATAACATCCAGGACGAAACCG Reference GTCAATTTAAACCGTACCCGGCGAGTAATTTCTCCACGGCCGTTCCGCAGAGTGCAACCGCTATGCTGGTCACGGCACTG sample02 GTCAATTTAAACCGTACCCGGCGAGTAATTTCTCCACGGCCGTTCCGCAGAGTGCAACCGCTATGCTGGTCACGGCACTG sample05 GTCAATTTAAACCGTACCCGGCGAGTAATTTCTCCACGGCCGTTCCGCAGAGTGCAACCGCTATGCTGGTCACGGCACTG sample06 GTCAATTTAAACCGTACCCGGCGAGTAATTTCTCCACGGCCGTTCCGCAGAGTGCAACCGCTATGCTGGTCACGGCACTG sample09 GTCAATTTAAACCGTACCCGGCGAGTAATTTCTCCACGGCCGTTCCGCAGAGTGCAACCGCTATGCTGGTCACGGCACTG sample10 GTCAATTTAAACCGTACCCGGCGAGTAATTTCTCCACGGCCGTTCCGCAGAGTGCAACCGCTATGCTGGTCACGGCACTG Reference AAAGATTCCCGTTGGTTCATTCCGCTGGAACGCCAGGGCCTGCAAAACCTGCTGAATGAACGTAAAATTATCCGCGCAGC sample02 AAAGATTCCCGTTGGTTCATTCCGCTGGAACGCCAGGGCCTGCAAAACCTGCTGAATGAACGTAAAATTATCCGCGCAGC sample05 AAAGATTCCCGTTGGTTCATTCCGCTGGAACGCCAGGGCCTGCAAAACCTGCTGAATGAACGTAAAATTATCCGCGCAGC sample06 AAAGATTCCCGTTGGTTCATTCCGCTGGAACGCCAGGGCCTGCAAAACCTGCTGAATGAACGTAAAATTATCCGCGCAGC sample09 AAAGATTCCCGTTGGTTCATTCCGCTGGAACGCCAGGGCCTGCAAAACCTGCTGAATGAACGTAAAATTATCCGCGCAGC sample10 AAAGATTCCCGTTGGTTCATTCCGCTGGAACGCCAGGGCCTGCAAAACCTGCTGAATGAACGTAAAATTATCCGCGCAGC Reference TCAGGAAAACGGTACCGTGGCCATTAACAATCGTATTCCGCTGCAAAGCCTGACCGCCGCAAACATCATGGTTGAAGGCT sample02 TCAGGAAAACGGTACCGTGGCCATTAACAATCGTATTCCGCTGCAAAGCCTGACCGCCGCAAACATCATGGTTGAAGGCT sample05 TCAGGAAAACGGTACCGTGGCCATTAACAATCGTATTCCGCTGCAAAGCCTGACCGCCGCAAACATCATGGTTGAAGGCT sample06 TCAGGAAAACGGTACCGTGGCCATTAACAATCGTATTCCGCTGCAAAGCCTGACCGCCGCAAACATCATGGTTGAAGGCT sample09 TCAGGAAAACGGTACCGTGGCCATTAACAATCGTATTCCGCTGCAAAGCCTGACCGCCGCAAACATCATGGTTGAAGGCT sample10 TCAGGAAAACGGTACCGTGGCCATTAACAATCGTATTCCGCTGCAAAGCCTGACCGCCGCAAACATCATGGTTGAAGGCT Reference CTATCATCGGTTACGAATCAAACGTCAAATCGGGCGGTGTGGGCGCACGTTATTTTGGCATTGGTGCTGATACCCAGTAC sample02 CTATCATCGGTTACGAATCAAACGTCAAATCGGGCGGTGTGGGCGCACGTTATTTTGGCATTGGTGCTGATACCCAGTAC sample05 CTATCATCGGTTACGAATCAAACGTCAAATCGGGCGGTGTGGGCGCACGTTATTTTGGCATTGGTGCTGATACCCAGTAC sample06 CTATCATCGGTTACGAATCAAACGTCAAATCGGGCGGTGTGGGCGCACGTTATTTTGGCATTGGTGCTGATACCCAGTAC sample09 CTATCATCGGTTACGAATCAAACGTCAAATCGGGCGGTGTGGGCGCACGTTATTTTGGCATTGGTGCTGATACCCAGTAC sample10 CTATCATCGGTTACGAATCAAACGTCAAATCGGGCGGTGTGGGCGCACGTTATTTTGGCATTGGTGCTGATACCCAGTAC Reference CAACTGGACCAGATCGCAGTTAACCTGCGCGTGGTTAATGTCAGCACCGGCGAAATTCTGAGCTCTGTGAATACCAGCAA sample02 CAACTGGACCAGATCGCAGTTAACCTGCGCGTGGTTAATGTCAGCACCGGCGAAATTCTGAGCTCTGTGAATACCAGCAA sample05 CAACTGGACCAGATCGCAGTTAACCTGCGCGTGGTTAATGTCAGCACCGGCGAAATTCTGAGCTCTGTGAATACCAGCAA sample06 CAACTGGACCAGATCGCAGTTAACCTGCGCGTGGTTAATGTCAGCACCGGCGAAATTCTGAGCTCTGTGAATACCAGCAA sample09 CAACTGGACCAGATCGCAGTTAACCTGCGCGTGGTTAATGTCAGCACCGGCGAAATTCTGAGCTCTGTGAATACCAGCAA sample10 CAACTGGACCAGATCGCAGTTAACCTGCGCGTGGTTAATGTCAGCACCGGCGAAATTCTGAGCTCTGTGAATACCAGCAA Reference AACGATCCTGTCTTACGAAGTGCAGGCTGGTGTTTTTCGTTTCATTGATTATCAACGCCTGCTGGAAGGCGAAGTCGGTT sample02 AACGATCCTGTCTTACGAAGTGCAGGCTGGTGTTTTTCGTTTCATTGATTATCAACGCCTGCTGGAAGGCGAAGTCGGTT sample05 AACGATCCTGTCTTACGAAGTGCAGGCTGGTGTTTTTCGTTTCATTGATTATCAACGCCTGCTGGAAGGCGAAGTCGGTT sample06 AACGATCCTGTCTTACGAAGTGCAGGCTGGTGTTTTTCGTTTCATTGATTATCAACGCCTGCTGGAAGGCGAAGTCGGTT sample09 AACGATCCTGTCTTACGAAGTGCAGGCTGGTGTTTTTCGTTTCATTGATTATCAACGCCTGCTGGAAGGCGAAGTCGGTT sample10 AACGATCCTGTCTTACGAAGTGCAGGCTGGTGTTTTTCGTTTCATTGATTATCAACGCCTGCTGGAAGGCGAAGTCGGTT Reference ACACCTCAAACGAACCGGTGATGCTGTGTCTGATGTCGGCGATTGAAACGGGTGTTATTTTCCTGATCAATGATGGCATC sample02 ACACCTCAAACGAACCGGTGATGCTGTGTCTGATGTCGGCGATTGAAACGGGTGTTATTTTCCTGATCAATGATGGCATC sample05 ACACCTCAAACGAACCGGTGATGCTGTGTCTGATGTCGGCGATTGAAACGGGTGTTATTTTCCTGATCAATGATGGCATC sample06 ACACCTCAAACGAACCGGTGATGCTGTGTCTGATGTCGGCGATTGAAACGGGTGTTATTTTCCTGATCAATGATGGCATC sample09 ACACCTCAAACGAACCGGTGATGCTGTGTCTGATGTCGGCGATTGAAACGGGTGTTATTTTCCTGATCAATGATGGCATC sample10 ACACCTCAAACGAACCGGTGATGCTGTGTCTGATGTCGGCGATTGAAACGGGTGTTATTTTCCTGATCAATGATGGCATC Reference GACCGTGGTCTGTGGGATCTGCAGAACAAAGCCGAACGTCAAAATGACATTCTGGTGAAATACCGCCACATGAGTGTTCC sample02 GACCGTGGTCTGTGGGATCTGCAGAACAAAGCCGAACGTCAAAATGACATTCTGGTGAAATACCGCCACATGAGTGTTCC sample05 GACCGTGGTCTGTGGGATCTGCAGAACAAAGCCGAACGTCAAAATGACATTCTGGTGAAATACCGCCACATGAGTGTTCC sample06 GACCGTGGTCTGTGGGATCTGCAGAACAAAGCCGAACGTCAAAATGACATTCTGGTGAAATACCGCCACATGAGTGTTCC sample09 GACCGTGGTCTGTGGGATCTGCAGAACAAAGCCGAACGTCAAAATGACATTCTGGTGAAATACCGCCACATGAGTGTTCC sample10 GACCGTGGTCTGTGGGATCTGCAGAACAAAGCCGAACGTCAAAATGACATTCTGGTGAAATACCGCCACATGAGTGTTCC Reference ACCAGAATCCTAATGAGCAGCAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGG sample02 ACCAGAATCCTAATGAGCAGCAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGG sample05 ACCAGAATCCTAATGAGCAGCAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGG sample06 ACCAGAATCCTAATGAGCAGCAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGG sample09 ACCAGAATCCTAATGAGCAGCAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGG sample10 ACCAGAATCCTAATGAGCAGCAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGG Reference GTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGC sample02 GTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGC sample05 GTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGC sample06 GTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGC sample09 GTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGC sample10 GTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGC Reference GTAACTGGACTGCAATCAACTCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAA sample02 GTAACTGGACTGCAATCAACTCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAA sample05 GTAACTGGACTGCAATCAACTCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAA sample06 GTAACTGGACTGCAATCAACTCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAA sample09 GTAACTGGACTGCAATCAACTCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAA sample10 GTAACTGGACTGCAATCAACTCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAA Reference AGTTACCCA sample02 AGTTACCCA sample05 AGTTACCCA sample06 AGTTACCCA sample09 AGTTACCCA sample10 AGTTACCCA
Reference GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA sample03 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA sample04 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA sample07 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA sample08 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA sample11 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA sample12 GACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGAGTGCGAAGGCTGCTGAA Reference GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT sample03 GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT sample04 GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT sample07 GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT sample08 GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT sample11 GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT sample12 GGTTATGAACAAATCGAAGTTGATGTGGTTGCTGTGTGGAAGGAAGGTTATGTGTATGAAAATCGTGGTAGTACCTCCGT Reference GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG sample03 GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG sample04 GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG sample07 GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG sample08 GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG sample11 GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG sample12 GGATCAAAAAATTACCATCACGAAAGGCATGAAGAACGTTAATAGCGAAACCCGTACGGTCACCGCGACGCATTCTATTG Reference GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA sample03 GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA sample04 GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA sample07 GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA sample08 GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA sample11 GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA sample12 GCAGTACCATCTCCACGGGTGACGCCTTTGAAATCGGCTCCGTGGAAGTTTCATATTCGCATAGCCACGAAGAATCACAA Reference GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC sample03 GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC sample04 GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC sample07 GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC sample08 GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC sample11 GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC sample12 GTTTCGATGACCGAAACGGAAGTCTACGAATCAAAAGTGATTGAACACACCATTACGATCCCGCCGACCTCGAAGTTCAC Reference GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG sample03 GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG sample04 GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG sample07 GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG sample08 GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG sample11 GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG sample12 GCGCTGGCAGCTGAACGCAGATGTCGGCGGTGCTGACATTGAATATATGTACCTGATCGATGAAGTTACCCCGATTGGCG Reference GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA sample03 GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA sample04 GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA sample07 GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA sample08 GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA sample11 GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA sample12 GTACGCAGAGTATTCCGCAAGTGATCACCTCCCGTGCAAAAATTATCGTTGGTCGCCAGATTATCCTGGGCAAGACCGAA Reference ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA sample03 ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA sample04 ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA sample07 ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA sample08 ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA sample11 ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA sample12 ATTCGTATCAAACATGCTGAACGCAAGGAATATATGACCGTGGTTAGCCGTAAATCTTGGCCGGCGGCCACGCTGGGTCA Reference CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT sample03 CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT sample04 CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT sample07 CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT sample08 CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT sample11 CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT sample12 CAGTAAACTGTTTAAGTTCGTGCTGTACGAAGATTGGGGCGGTTTTCGCATCAAAACCCTGAATACGATGTATTCTGGTT Reference ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT sample03 ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT sample04 ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT sample07 ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT sample08 ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT sample11 ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT sample12 ATGAATACGCGTATAGCTCTGACCAGGGCGGTATCTACTTCGATCAAGGCACCGACAACCCGAAACAGCGTTGGGCCATT Reference AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA sample03 AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA sample04 AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA sample07 AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA sample08 AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA sample11 AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA sample12 AATAAGAGCCTGCCGCTGCGCCATGGTGATGTCGTGACCTTTATGAACAAATACTTCACGCGTTCTGGTCTGTGCTATGA Reference TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG sample03 TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG sample04 TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG sample07 TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG sample08 TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG sample11 TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG sample12 TGACGGCCCGGCGACCAATGTGTATTGTCTGGATAAACGCGAAGACAAGTGGATTCTGGAAGTTGTCGGATAATGAGCAG Reference CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA sample03 CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA sample04 CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA sample07 CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA sample08 CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA sample11 CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA sample12 CAGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGA Reference ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC sample03 ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC sample04 ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC sample07 ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC sample08 ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC sample11 ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC sample12 ACTATATCCGGGTAACGAATTCAAGCTTGATATCATTCAGGACGAGCCTCAGACTCCAGCGTAACTGGACTGCAATCAAC Reference TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA sample03 TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA sample04 TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA sample07 TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA sample08 TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA sample11 TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA sample12 TCACTGGCTCACCTTCACGGGTGGGCCTTTCTTCGGGATCCGCGCTGCGGACACATACAAAGTTACCCA
Insert QC
This section can be used to ensure the provided insert reference matches the insert found in the assembly. The table belows shows coverage and BLAST identity between the two. Reference coverage is the percentage of the provided insert reference sequence covered in the alignment with the assembled construct. Assembly coverage is the percentage of the assembled insert sequence covered in the alignment with the provided insert reference. BLAST identity is calculated as: (length - ins - del - sub) / length. If both coverage and identity are 0, the assembled insert did not align with the provided insert reference.
Sample name | Reference coverage | Assembly coverage | BLAST Identity |
---|---|---|---|
sample02 | 100.0 | 100.0 | 100.0 |
sample03 | 100.0 | 100.0 | 100.0 |
sample04 | 100.0 | 100.0 | 100.0 |
sample05 | 100.0 | 100.0 | 100.0 |
sample06 | 100.0 | 100.0 | 100.0 |
sample07 | 100.0 | 100.0 | 100.0 |
sample08 | 100.0 | 100.0 | 100.0 |
sample09 | 100.0 | 100.0 | 100.0 |
sample10 | 100.0 | 100.0 | 100.0 |
sample11 | 100.0 | 100.0 | 100.0 |
sample12 | 100.0 | 100.0 | 100.0 |
Insert variants
The following tables and figures are output from bcftools from finding any variants between the consensus insert and the provided reference insert.
Variant counts per sample. See output bcf file for info on individual variants.
filename | id | MNPs | SNPs | indels | multiallelic SNP sites | multiallelic sites | no-ALTs | others | records |
---|---|---|---|---|---|---|---|---|---|
sample02.insert.stats | sample02.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample03.insert.stats | sample03.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample04.insert.stats | sample04.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample05.insert.stats | sample05.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample06.insert.stats | sample06.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample07.insert.stats | sample07.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample08.insert.stats | sample08.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample09.insert.stats | sample09.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample10.insert.stats | sample10.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample11.insert.stats | sample11.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample12.insert.stats | sample12.insert.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trans counts per sample. See output bcf file for info on individual transitions.
filename | id | ts | tv | ts/tv | ts (1st ALT) | tv (1st ALT) | ts/tv (1st ALT) |
---|---|---|---|---|---|---|---|
sample02.insert.stats | sample02.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample03.insert.stats | sample03.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample04.insert.stats | sample04.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample05.insert.stats | sample05.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample06.insert.stats | sample06.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample07.insert.stats | sample07.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample08.insert.stats | sample08.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample09.insert.stats | sample09.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample10.insert.stats | sample10.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample11.insert.stats | sample11.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample12.insert.stats | sample12.insert.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
Full construct QC
This section can be used to ensure the provided reference matches the assembly. The table belows shows coverage and BLAST identity between the provided reference and assembly. Reference coverage is the percentage of the provided reference sequence covered in the alignment with the assembled construct. Assembly coverage is the percentage of assembled contruct sequence covered in the alignment with the provided reference. BLAST Identity is calculated as: (length - ins - del - sub) / length. If both coverage and identity are 0, the assembly did not align with the provided reference.
Sample name | Reference coverage | Assembly coverage | BLAST Identity |
---|---|---|---|
sample02 | 100.0 | 100.0 | 94.57 |
sample03 | 99.3825 | 98.7726 | 100.0 |
sample04 | 99.3825 | 98.773 | 99.97 |
sample05 | 100.0 | 100.0 | 100.0 |
sample06 | 100.0 | 100.0 | 99.97 |
sample07 | 99.3825 | 98.7726 | 100.0 |
sample08 | 99.3825 | 98.7726 | 100.0 |
sample09 | 100.0 | 100.0 | 100.0 |
sample10 | 100.0 | 100.0 | 100.0 |
sample11 | 99.3825 | 98.7726 | 100.0 |
sample12 | 99.3825 | 98.7726 | 100.0 |
Additionally, BCFtools was used to report any variants between the provided reference and assembly.
Variant counts per sample. See output bcf file for info on individual variants.
filename | id | MNPs | SNPs | indels | multiallelic SNP sites | multiallelic sites | no-ALTs | others | records |
---|---|---|---|---|---|---|---|---|---|
sample02.full_construct.stats | sample02.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample03.full_construct.stats | sample03.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample04.full_construct.stats | sample04.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample05.full_construct.stats | sample05.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample06.full_construct.stats | sample06.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample07.full_construct.stats | sample07.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample08.full_construct.stats | sample08.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample09.full_construct.stats | sample09.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample10.full_construct.stats | sample10.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample11.full_construct.stats | sample11.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
sample12.full_construct.stats | sample12.full_construct.stats | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trans counts per sample. See output bcf file for info on individual transitions.
filename | id | ts | tv | ts/tv | ts (1st ALT) | tv (1st ALT) | ts/tv (1st ALT) |
---|---|---|---|---|---|---|---|
sample02.full_construct.stats | sample02.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample03.full_construct.stats | sample03.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample04.full_construct.stats | sample04.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample05.full_construct.stats | sample05.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample06.full_construct.stats | sample06.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample07.full_construct.stats | sample07.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample08.full_construct.stats | sample08.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample09.full_construct.stats | sample09.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample10.full_construct.stats | sample10.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample11.full_construct.stats | sample11.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |
sample12.full_construct.stats | sample12.full_construct.stats | 0 | 0 | 0.0 | 0 | 0 | 0.0 |